Nov 03, 2020 / 11:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Eris Lifesciences Q2 and H1 FY 2021 Results Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Amit Bakshi from -- Chairman and Managing Director of the company. Thank you, and over to you, sir.
Amit Indubhushan Bakshi - Eris Lifesciences Limited - Chairman & MD
Thank you. Thank you. Thanks, everybody, for attending the call. A very good evening. Let me start by saying how things moved from quarter 1 to quarter 2. At the macro level, we are almost back at around 90% of work. The footfall [in the doctors' clinics] have also more or less come to the normal levels. So I would presume they are at around 90%.
The initial thought which we had when we opened the quarter 1 call, I remembered that, there could be a structural change going forward. Though we didn't have the numbers at that point of time to really speak for it. But we were quite hopeful that going forward, there might be a structural shift in the way our team
Q2 2021 Eris Lifesciences Ltd Earnings Call Transcript
Nov 03, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers